General requirements for publications
Articles that meet all the requirements listed below and have not been previously published and sent for consideration to the editors of other journals are submitted to the journal.
The authors are responsible for the authenticity and originality of their materials. The Editorial Board reserves the right to shorten and edit the articles.
Articles are printed in Ukrainian, Russian and English.
Requirements to the content of the article
The Editorial Board accepts review articles, short communications and original research articles for consideration. These articles can contain the results of research on development of methods for synthesis of organic and elementorganic compounds; purposeful synthesis of novel and naturally occurring compounds with desirable pharmacological properties; investigation of the structure, chemical, physical and biological properties of novel and naturally occurring compounds; study of chemical kinetic and mechanisms of the reactions; pharmacological screening and «structure – bioactivity» relationships of organic compounds; development, improving and validation of methods for qualitative and quantitative analysis of chemicals, including bioactive compounds, active pharmaceutical ingredients, drug products, dietary supplements etc.; development and validation of bioanalytical methods for application in toxicological analysis, pharmacokinetic investigations etc.; standardization and quality control of the drug products.
Requirements to the structure of the article
Authors should follow the general plan for constructing the article containing the subdivisions, which titles are indicated by semi-bold without a point at the end. The text begins from a new line.
The article should contain the following obligatory subdivisions:
Introduction. The introduction determines the task setting in general and its connection with important scientific or practical tasks. It is necessary to include the analysis of recent researches and publications, as well as to analyze the literature concerning the topic of the article and the authors’ own previous publications about this topic that outline the given scientific problem. This section should indicate the results that the authors of the previous publications succeeded to obtain and unresolved issues. The title of this subdivision may not be given in the article.
The aim contains the task setting.
Materials and methods (or Experimental part). It contains a description of methods and procedures as well as characterization of compounds that should give a clear idea of the objectivity of the results obtained. This section may be given after the subdivision Results and discussion.
Results and discussion. This section comprises the results of research done by the author. They must be clearly and exhaustively described with full substantiation of the research results obtained. The title of this subdivision may not be given in the article.
Conclusions. This section contains the main conclusions of a particular research, their further application, a critical assessment of disadvantages of studying the problem and the prospects for further research in a particular direction.
Conflict of interests. Any potential conflicts of interest should be considered at the earliest possible stage. Examples of potential conflicts of interest are: paid research, advice, patent applications, grants or other funding, personal relationships of authors with other people or organizations. The Editorial Office should apply the Elsevier policy to disclose potential conflicts of interest by authors and reviewers.
The list of the information sources used (References) is located by its reference in the text.
The article must contain information about all authors, including the full name, academic title, academic degree; place of work and position of the author; country name, telephone numbers, e-mail for correspondence (without underscores), ORCID and Researcher ID (if available).
Requirements for the technical design of the article
The text of the article is printed in size 14 in 1.5 spacing, Times New Roman on a sheet of A4 format (the width of the fields: 3 cm on the left, 1 cm on the right, 2 cm on the top and at the bottom) and begins with the following data:
1. UDC (in the upper left corner).
2. Initials and surnames of the authors.
3. Place of work (name of the organization, country); if authors are from different organizations, they are numbered using an upper sign.
4. The title of the article (semi-bold) should contain 10 – 12 words, but not more than 95 symbols, together with spaces.
5. The abstract is provided in two languages (Ukrainian, English), but first in the language of the article. It contains the following subdivisions: Aim, Materials and methods (Experimental part), Results and discussion, Conclusions, Key words. All subdivisions begin with a paragraph. The volume should be at least 1800 signs. It is recommended to build sentences according to the following model: «It has been found (determined, proven) ...», «The contribution / effect / role has been assessed ...», «The regularities have been characterized...», «It has been considered that...», etc.
6. The phrase «Key words» begins from a new line in the language of the article in italics (keywords are needed for search engines and the classification of articles by subject); english key words for articles are desirable to be selected by the authors from the MeSH index of the National Library of Medicine of the United States https: https://www.nlm.nih.gov/mesh/; it is in the interest of the author to specify the number of key words needed to increase the chances of finding the article through search engines; word combinations are considered as one key word; the number of keywords is 5 – 8.
7. The use of trademarks should be as limited as possible in the names, abstract and key words. Medicines in the text should be mentioned by their international non-proprietary names. In cases where the manufacturer of the medicine is important in the context of the study the name of the manufacturer is mentioned in brackets after the unpatented name.
8. The text of the article is given after the abstract in an interval, paragraph indentation – 1 cm.
9. The system of SI units should be used in the articles.
10. References in the text of the article are given in square brackets indicating the serial number in the list of literature. The source numbers are separated by a comma, for example: [7, 8, 12]. The point in the sentence put after brackets of the references.
11. Figures and tables are done in accordance with DSTU 3008-95 and are located in the text strictly within the printed field of the book orientation of pages; all text information in the figures should be clear and legible, it should not contain any unnecessary details; each figure has a caption (not combined with the figure), and the table has a heading (center alignment); all figures and tables must be numbered sequentially in Arabic numerals; it is advisable to add colorful illustrative material in .jpg, .tiff, .pcx, and similar graphics in the form of additional individual files with the names fig1, fig2.
12. The formulas must have a sequential numbering from the right field; they should be added in additional separate files in such formats as Corel Draw 13; Chem Win, ISISdraw; charts and figures – in Excel or Corel Draw 13.
13. The information in tables and figures should not be duplicated.
14. The list of the information sources used (References) is given in semi-bold letters in an interval in the center, the numbering of the sources in the order of mentioning in the text, without indentation; references should include publications for the last 10 years if there is no reason to mention other primary sources.
15. The list of the sources of information used must meet the standard CAS; a reference in the text of the article should be made for each work in the list of references.
16. The basis of the reference base should be scientific articles published in the prestigious journals of the same direction over the last few years; citation of monographs and conference reports should not constitute a significant percentage of the source base; it is necessary to limit the references to non-authoritative web resources, methodical recommendations, textbooks, manuals, conference abstracts; links to URLs must necessarily include the date of reference to them; authors should use the rules for abbreviations of titles of publications in references to the ISO / Medline / CAS standards; if there is the DOI identifier of the articles quoted, they must be specified.
17. The list of the information sources used is given according to CAS standard in an interval in Ukrainian and Russian, transliterated with roman letters. Names of authors, titles of books (journals, conferences), articles, etc., are transliterated, and in square brackets the translation of titles into English is provided. To transliterate the sources into Ukrainian, it is recommended to use the Resolution of the Cabinet of Ministers No. 55 «On Structuring the Transliteration of the Ukrainian Alphabet with roman letters» dated January 27, 2010 (http://zakon2.rada.gov.ua/laws/show/55-2010-%D0%BF).
18. Information about the authors is given in two languages, but first in the language of the article.
Articles sent to the authors for correction must be returned to the Editorial Office no later than 3 days after receipt. In the author’s proofreading it is allowed to correct typing errors. After approval of the original layout by all authors and editors the editors do not accept the claim of the authors.
After the final agreement of the articles the authors are sent an Agreement on the provision of services for the editorial preparation of a scientific article for publishing. This agreement with a payment receipt must be returned to the Publishing Center of the NUPh.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
Names and e-mails provided by users of the journal web-site will be used exclusively for internal purposes of editorial staff and will not be shared with and passed to unauthorized persons.